FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Road to Brexit
Economy
The Trump Effect
Detained in Myanmar
Environment
Sport
Royal Wedding
Lifestyle
Healthcare
January 26, 2018 / 7:13 AM / 3 months ago

BRIEF-AstraZeneca Reports Positive Phase III Results For PT010 In COPD

Reuters Staff

1 Min Read

Jan 26 (Reuters) - AstraZeneca Plc:

* AZ REPORTS PHASE III RESULTS FOR PT010 IN COPD

* ‍PT010 DEMONSTRATES SIGNIFICANT IMPROVEMENT IN 8 OUT OF NINE LUNG FUNCTION PRIMARY ENDPOINTS COMPARED WITH DUAL COMBINATION THERAPIES​

* ‍THERE WERE NO UNEXPECTED SAFETY OR TOLERABILITY SIGNALS FOR PT010 IDENTIFIED IN TRIAL​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.